<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="23" ids="18059">Lipid</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) levels were investigated in 98 (68 female, 30 male) subjects older than 85 years and 86 (59 female, 27 male) subjects aged 65-75 years </plain></SENT>
<SENT sid="1" pm="."><plain>The mean cholesterol level of the long-lived persons who were free from overt degenerative <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arterial disease</z:e> was 5.2 mmol/l and ranged markedly below the mean level of the population </plain></SENT>
<SENT sid="2" pm="."><plain>Comparing both age groups, the <z:chebi fb="0" ids="17855">triglyceride</z:chebi> level of the high-age subjects was at 0.3 mmol/l, significantly lower; <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> and apo A-I at 0.15 mmol/l or 0.3 g/l were higher </plain></SENT>
<SENT sid="3" pm="."><plain>Cholesterol, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, and apo B only tended to be lower in the higher age </plain></SENT>
<SENT sid="4" pm="."><plain>Subjects suffering from degenerative <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arterial disease</z:e> (circulatory disturbance, <z:hpo ids='HP_0001276'>hypertonia</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>), especially the long-lived group, had a more marked unfavorable <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> profile </plain></SENT>
<SENT sid="5" pm="."><plain>Subjects over 85 years (13%) had markedly less disturbance in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism of high atherogenic potency (hyper-beta-, <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypo-alpha-lipoproteinemia</z:e>) than did subjects 65-75 years old (23%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> is with 38% or rather 21% very frequent and seems to be of less atherogenic potency </plain></SENT>
<SENT sid="7" pm="."><plain>Hyper-<z:e sem="disease" ids="C0241784" disease_type="Disease or Syndrome" abbrv="">alpha-lipoproteinemia</z:e> as anti-risk factor for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart diseases</z:e> was established more frequently in the long-lived group with 13% in comparison to 3.5% in those 65-75 years of age </plain></SENT>
</text></document>